GNRH1 and ovarian hyperstimulation syndrome: The use of a GnRH agonist (GnRHa) instead of recombinant hCG for triggering final oocyte maturation significantly reduces the risk of developing OHSS in GnRH antagonist IVF cycles (4, 5).